dc.date.accessioned | 2021-03-24T20:27:59Z | |
dc.date.available | 2021-03-24T20:27:59Z | |
dc.date.created | 2021-01-05T14:23:33Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Harbin, Nicolay Jonassen Haug, Jon Birger Romøren, Maria Lindbæk, Morten . Oral and parenteral antibiotic use in Norwegian nursing homes: are primary care institutions becoming our new local hospitals?. JAC-Antimicrobial Resistance (JAC-AMR). 2020, 2(4) | |
dc.identifier.uri | http://hdl.handle.net/10852/84719 | |
dc.description.abstract | Abstract
Background
Norwegian nursing homes (NHs) have over the last 10 years increasingly applied the use of parenteral treatment, which in turn allows more broad-spectrum use of antibiotics. Previous studies from Norwegian NHs have for the most part not described parenteral formulations.
Objectives
To describe systemic antibiotic use in Norwegian NHs.
Methods
Thirty-seven NHs in the county of Østfold, Norway, were invited to participate in this retrospective cross-sectional study. Associated pharmacies provided sales data for systemic antibiotic use for the participating NHs for 1 year (October 2015 to October 2016). General institutional characteristics were collected through a questionnaire.
Results
Thirty-four NHs participated in the study. Mean use of antibiotics was 10.0 DDD/100 bed days (range 0.6–30.9 DDD/100 bed days). Oral antibiotics accounted for 83% and parenteral antibiotics for 17% of the total antibiotic use. Of parenteral antibiotics, ampicillin was most used (31.1%) followed by cefotaxime (17.7%) and penicillin G (16.6%). The proportion of antibiotics compliant with guideline recommendations was 60%. Being a short-term NH was associated with increased antibiotic use, with an unstandardized coefficient of 13.1 (95% CI 4.2–21.9; P = 0.005).
Conclusions
We found a high level of total and parenteral antibiotic use compared with previous studies from Norwegian NHs. Data showed wide variations in total antibiotic use and that only a moderate proportion of the antibiotic use was considered guideline compliant. This highlights the necessity of further implementation strategies regarding the national guidelines for antibiotic use in NHs. | |
dc.language | EN | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.title | Oral and parenteral antibiotic use in Norwegian nursing homes: are primary care institutions becoming our new local hospitals? | |
dc.type | Journal article | |
dc.creator.author | Harbin, Nicolay Jonassen | |
dc.creator.author | Haug, Jon Birger | |
dc.creator.author | Romøren, Maria | |
dc.creator.author | Lindbæk, Morten | |
cristin.unitcode | 185,52,15,0 | |
cristin.unitname | Avdeling for allmennmedisin | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1865660 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=JAC-Antimicrobial Resistance (JAC-AMR)&rft.volume=2&rft.spage=&rft.date=2020 | |
dc.identifier.jtitle | JAC-Antimicrobial Resistance (JAC-AMR) | |
dc.identifier.volume | 2 | |
dc.identifier.issue | 4 | |
dc.identifier.pagecount | 8 | |
dc.identifier.doi | https://doi.org/10.1093/jacamr/dlaa093 | |
dc.identifier.urn | URN:NBN:no-87444 | |
dc.type.document | Tidsskriftartikkel | |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 2632-1823 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/84719/2/Oral%2Band%2Bparenteral%2Bantibiotic%2Buse%2Bin%2Bnursing%2Bhomes_RASK.pdf | |
dc.type.version | PublishedVersion | |
dc.relation.project | OTHER/AFF | |